Member access

4-Traders Homepage  >  Shares  >  Nyse  >  Allergan, Inc.    AGN   US0184901025

ALLERGAN, INC. (AGN)

40
SummaryQuotesChart AnalysisNewsCalendarCompanyFinancialsConsensusRevisions 
News SummaryMost relevantAll news 
Latest news on ALLERGAN, INC.
2d ago ALLERGAN : eVivite.com Continues to Sell VIVITÉ® Products After Allergan Announc..
2d ago ALLERGAN : Posts Third Quarter Results
3d ago ALLERGAN : Patent Issued for Intragastric Implants with Collapsible Frames
4d ago ALLERGAN : New Allergan Campaign #THISISME Empowers Women To Age The Way They Wa..
4d ago ALLERGAN : NYSE:AGN) Investor Alert: Investigation over Potential Wrongdoing by ..
4d ago ALLERGAN : Assigned Patent
5d ago ALLERGAN : Pharmaceuticals Valiant to inject more cash into Allergan offer
5d agoDJMARKET SNAPSHOT : Energy Stocks Sap S&P 500
5d agoDJMARKET SNAPSHOT : U.S. Stocks Retreat; Energy Stocks Sell Off
5d agoDJMARKET SNAPSHOT : U.S. Stocks Retreat; Energy Stocks Sell Off
5d ago Valeant says ready to raise Allergan bid to at least $200/share
5d agoDJValeant Hints at Higher Allergan Bid -- 6th Update
5d agoDJValeant Hints at Higher Allergan Bid -- 5th Update
5d ago Valeant ready to raise Allergan bid to at least $200/share
5d agoDJMARKET SNAPSHOT : U.S. Stocks Retreat; Energy Stocks Sell Off
5d ago ALLERGAN : Other Events, Financial Statements and Exhibits (form 8-K)
5d agoDJMARKET SNAPSHOT : U.S. Stocks Retreat; Energy Stocks Sell Off
5d agoDJMARKET SNAPSHOT : U.S. Stock Retreat; Energy Stocks Sell Off
5d agoDJValeant Hints at Higher Allergan Bid -- 4th Update
5d ago ALLERGAN : Comments on Valeant Letter
5d agoDJValeant Hints at Higher Allergan Bid -- 3rd Update
5d agoDJMARKET SNAPSHOT : U.S. Stock: Futures Fall; Focus On Fed
5d agoDJValeant Hints at Higher Allergan Bid -- 2nd Update
5d ago ALLERGAN : Results of Operations and Financial Condition, Financial Statements a..
5d agoDJMARKET SNAPSHOT : Stock Futures Flatten After Weak German Data; Focus On Fed
5d ago ALLERGAN : Valeant tells Allergan board it's prepared to raise offer to US$200 p..
5d ago ALLERGAN : Valeant: We'll bump Allergan offer to $200 a share
5d ago ALLERGAN : tops Street 3Q forecasts
5d ago ALLERGAN : Reports Third Quarter 2014 Operating Results
5d agoDJMARKET SNAPSHOT : Stock Futures Flatten After Weak German Data; Focus On Fed
6d ago ALLERGAN : David Pyott Recognized by Harvard Business Review
10/24 ALLERGAN : Announces Quarterly Conference Call
10/23 ALLERGAN : Patent Issued for Variable Cohesive Gel Form-Stable Breast Implant
10/23 ALLERGAN : Patent Issued for Interior Needle Stick Guard Stems for Tubes
10/23 ALLERGAN : Patent Issued for Compositions Containing Alpha-2-Adrenergic Agonist ..
10/23 ALLERGAN : Patent Issued for Biological Tissue Growth through Induced Tensile St..
10/22 ALLERGAN : Harvard Business Review Ranks David Pyott One of the Top 5 CEOs in th..
10/21 JOHN PAULSON : John Paulson's Solution To Shire Problem Probably Not Sitting Wel..
10/21 Stronger oil stocks and surge in Shire lift FTSE
10/21 ALLERGAN : Ackman, Valeant lawyers say Allergan CEO oversaw campaign to discredi..
10/21 ALLERGAN : Valeant may up Allergan offer
10/21 Ackman, Valeant lawyers say Allergan CEO oversaw campaign to discredit Valean..
10/21 WILLIAM ACKMAN : Ackman, Valeant lawyers say Allergan CEO oversaw campaign to di..
10/20 TSX advances with gold miners, Valeant
10/20 Top Allergan holder Paulson urges deal with Shire - sources
10/20 TOP ALLERGAN HOLDER PAULSON URGES DE : sources
10/20 Valeant says may raise Allergan bid; beats on profit
10/20 Valeant CEO sees revised Allergan bid worth more than $200 per share
10/20 Valeant may raise Allergan bid, says it won't walk away
10/20DJU.S. HOT STOCKS : Hot Stocks to Watch
10/20 ALLERGAN : Other Events, Financial Statements and Exhibits (form 8-K)
10/20 ALLERGAN : David Pyott Recognized by Harvard Business Review
10/16 ACKMAN : Lawyers have documents purported to show Allergan misled on Valeant
10/16 AbbVie board ditches planned $55 billion Shire acquisition
10/15 ALLERGAN : Patent Issued for Ester Pro-Drugs of Methanol for Treating Retinal Di..
10/15 ALLERGAN : Patent Issued for Polysaccharide Gel Formulation Having Increased Lon..
10/15 ALLERGAN : Harvard Business Review Ranks David Pyott One of the Top 5 CEOs in th..
10/14 Irish tax changes may cost U.S. groups billions
10/14 ALLERGAN : Dr. Rami Batniji Selected By Allergan To Test Their Total Facial Reju..
10/14 ALLERGAN : Offers Details of Earnings Per Share and Sales Expectations
10/14 ALLERGAN : Pershing Square debuts on Euronext Amsterdam
10/13 Activist investor Ackman's fund Pershing dips on Amsterdam debut
10/10 EXCLUSIVE - TOP ACTAVIS HOLDER, FIDE : sources
10/09 Allergan raises outlook; says Valeant offer undervalues company
10/09 ALLERGAN : Results of Operations and Financial Condition, Financial Statements a..
10/09 ALLERGAN : Provides Update on Earnings Per Share and Sales Expectations
10/09DJU.S. HOT STOCKS : Hot Stocks to Watch
10/08 ALLERGAN : Patent Issued for Targeted Delivery of Botulinum Toxin to the Sphenop..
10/08 ALLERGAN : Announces FDA Approves Revised Indication for OZURDEX® dexamethasone ..
10/08 ALLERGAN : Actavis plans Allergan offer
10/07 EXCLUSIVE : Actavis plans new merger approach for Allergan - sources
10/07 EXCLUSIVE - ACTAVIS PLANS NEW MERGER : sources
10/04 ALLERGAN : Assigned Patent
10/03 ALLERGAN : Researchers Submit Patent Application, "Composition of a Sustained-Re..
10/03 ALLERGAN : Researchers Submit Patent Application, "Prostanoid Receptor Agonist C..
1  2  3  4  5  6  7  8  9  10Next
Advertisement
Chart
Duration : Period :
Allergan, Inc. Technical Analysis Chart | AGN | US0184901025 | 4-Traders
Income Statement Evolution
More Financials
Dynamic quotes  
ON
| OFF